Recent Updates
Recently added Catalysts
ELDN Positive Sentiment

Milestone Pig-to-Human Heart Transplant May Pave the Way for Broader Trial

Key Takeaway: A significant milestone has been reached in the field of organ transplantation with a successful pig-to-human heart transplant. This achievement may lead to broader clinical trials, offering hope for patients in need of organ transplants. The advancement highlights the potential of xenotransplantation as a viable solution to organ shortages.
Price reaction · baseline $1.4599 (2023-10-25T18:20:00.000Z) · hit during market hours · 1 other ELDN headline(s) in the window, move may be shared
day 0 close · peak
-2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Milestone achievement in pig-to-human heart transplant.
  • Potential to pave the way for broader clinical trials.
  • Innovative approach to organ transplantation.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+90%
120-day peak, hindsight
Typical move
6.5%
average across 7 past catalysts
Cash runway
~11 mo
Medium dilution risk
Lead asset
AT-1501
Phase 2 · Kidney Transplant Rejection

Full Press Release Details

Transforming Lives. One Organ at a Time.
• Overview Focus Patient Stories Clinical Trials In The News
• Science Mechanism of Action Pipeline Publications & Presentations In The News
• Team Overview Leadership Board of Directors
• Investors Overview News & Events Press Releases Events Publications & Presentations Corporate Governance Governance Overview Committee Composition Ethics Hotline Financials SEC Filings Stock Information Stock Quote & Chart Analyst Coverage Resources Investor FAQs Email Alerts Contact IR
• Culture/Careers Culture Careers
• Contact
• Focus
• Patient Stories
• Clinical Trials
• In The News
• Mechanism of Action
• Pipeline
• Publications & Presentations
• In The News
• Overview
• Leadership
• Board of Directors
• Overview
• News & Events Press Releases Events Publications & Presentations
• Corporate Governance Governance Overview Committee Composition Ethics Hotline
• Financials SEC Filings
• Stock Information Stock Quote & Chart Analyst Coverage
• Resources Investor FAQs Email Alerts Contact IR
• Press Releases
• Events
• Publications & Presentations
• Governance Overview
• Committee Composition
• Ethics Hotline
• SEC Filings
• Stock Quote & Chart
• Analyst Coverage
• Investor FAQs
• Email Alerts
• Contact IR
• Culture
• Careers
• Privacy Overview
• Necessary
• Analytics
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.

Frequently Asked Questions

What is the significance of the pig-to-human heart transplant?

The transplant marks a milestone that could lead to broader clinical trials in organ transplantation.

How does this achievement impact organ transplant patients?

It offers hope for patients facing organ shortages by exploring innovative transplantation solutions.

What is xenotransplantation?

Xenotransplantation is the process of transplanting organs from one species to another, such as pigs to humans.

Last updated: Oct 25, 2023